Theme:
Light Dark Auto
GeneralTop StoriesPoliticsBusinessEconomyTechnologyInternationalEnvironmentScienceSportsHealthEducationEntertainmentLifestyleCultureCrime & LawTravel & TourismFood & RecipesFact CheckReligion
POLITICS
Positive Sentiment

Washington launches TrumpRx website to lower drug costs

Read, Watch or Listen

Media Bias Meter
Sources: 11
Center 83%
Right 17%
Sources: 11

Washington — President Donald Trump unveiled TrumpRx.gov on Thursday, a website designed to connect consumers with discounted prescription medicines. The White House announced a 7 p.m. ET launch and said the site will link users to manufacturers’ direct-purchase platforms rather than dispense drugs. Trump announced the initiative with CMS Administrator Dr. Mehmet Oz and National Design Studio Director Joe Gebbia. The administration said over a dozen drugmakers signed most-favored-nation agreements to offer lower cash prices, with GoodRx named a key integration partner. Officials said some GLP-1 prices could fall to $149–$350 per month. Based on 6 articles reviewed and supporting research.

Prepared by Lauren Mitchell and reviewed by editorial team.

Timeline of Events

  • September 2025: Administration first announced plans for a TrumpRx initiative to lower drug prices.
  • December 2025: Trump publicly described the forthcoming site as delivering substantial consumer discounts.
  • 5 February 2026 (scheduled): White House announced the 7:00 PM ET unveiling of TrumpRx.gov.
  • 5 February 2026, 7:00 PM ET: President Trump unveiled TrumpRx at the White House with Dr. Mehmet Oz and Joe Gebbia.
  • Post-launch: TrumpRx went live as a portal listing manufacturer cash prices; GoodRx integration was confirmed and MFN deals with multiple drugmakers were cited, including GLP-1 price targets.
Media Bias
Articles Published:
6
Right Leaning:
1
Left Leaning:
0
Neutral:
5

Who Benefited

Consumers paying cash for prescription drugs may benefit from lower listed cash prices via TrumpRx, participating drugmakers may gain broader U.S. market access under MFN arrangements, and partners like GoodRx could see increased transaction volume.

Who Impacted

Non-participating pharmacies and intermediaries could lose cash sales; patients without direct manufacturer channels or who rely on pharmacy dispensing may still face access or practical barriers despite listed discounts.

Media Bias
Articles Published:
6
Right Leaning:
1
Left Leaning:
0
Neutral:
5
Distribution:
Left 0%, Center 83%, Right 17%
Who Benefited

Consumers paying cash for prescription drugs may benefit from lower listed cash prices via TrumpRx, participating drugmakers may gain broader U.S. market access under MFN arrangements, and partners like GoodRx could see increased transaction volume.

Who Impacted

Non-participating pharmacies and intermediaries could lose cash sales; patients without direct manufacturer channels or who rely on pharmacy dispensing may still face access or practical barriers despite listed discounts.

Coverage of Story:

From Left

No left-leaning sources found for this story.

From Center

Washington launches TrumpRx website to lower drug costs

KOKH News Directory 3 heidoh.com Weekly Voice Free Malaysia Today
From Right

Trump to officially launch TrumpRX, offering affordable prescription drugs to Americans

KRCR

Related News

Comments

JQJO App
Get JQJO App
Read news faster on our app
GET